DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 216 filers reported holding DENALI THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $52,238,392 | -23.6% | 2,531,835 | +9.2% | 0.01% | -25.0% |
Q2 2023 | $68,412,963 | +38.4% | 2,318,297 | +8.0% | 0.01% | +33.3% |
Q1 2023 | $49,447,819 | +86636.9% | 2,146,172 | +4.7% | 0.01% | -25.0% |
Q4 2022 | $57,009 | -99.9% | 2,049,957 | +15.4% | 0.01% | 0.0% |
Q3 2022 | $54,510,000 | +8.5% | 1,776,164 | +4.1% | 0.01% | +14.3% |
Q2 2022 | $50,224,000 | -4.3% | 1,706,581 | +4.6% | 0.01% | 0.0% |
Q1 2022 | $52,467,000 | -27.8% | 1,630,947 | +0.1% | 0.01% | -22.2% |
Q4 2021 | $72,647,000 | -10.4% | 1,628,867 | +1.3% | 0.01% | -18.2% |
Q3 2021 | $81,093,000 | -31.9% | 1,607,394 | +6.0% | 0.01% | -31.2% |
Q2 2021 | $118,995,000 | +66.3% | 1,517,021 | +21.1% | 0.02% | +45.5% |
Q1 2021 | $71,536,000 | -26.0% | 1,252,832 | +8.5% | 0.01% | -31.2% |
Q4 2020 | $96,734,000 | +148.6% | 1,154,902 | +6.3% | 0.02% | +100.0% |
Q3 2020 | $38,916,000 | +48.9% | 1,086,129 | +0.5% | 0.01% | +33.3% |
Q2 2020 | $26,137,000 | +51.9% | 1,080,950 | +10.0% | 0.01% | +50.0% |
Q1 2020 | $17,203,000 | -43.1% | 982,519 | -43.4% | 0.00% | +33.3% |
Q4 2019 | $30,226,000 | +134.1% | 1,735,236 | +105.9% | 0.00% | 0.0% |
Q3 2019 | $12,911,000 | -24.5% | 842,771 | +2.3% | 0.00% | -25.0% |
Q2 2019 | $17,098,000 | -4.8% | 823,633 | +6.4% | 0.00% | -20.0% |
Q1 2019 | $17,968,000 | -38.8% | 773,887 | -45.5% | 0.01% | 0.0% |
Q4 2018 | $29,338,000 | +90.2% | 1,420,044 | +100.2% | 0.01% | +25.0% |
Q3 2018 | $15,421,000 | +390.6% | 709,345 | +244.1% | 0.00% | +300.0% |
Q2 2018 | $3,143,000 | +7.8% | 206,150 | +39.2% | 0.00% | 0.0% |
Q1 2018 | $2,915,000 | – | 148,078 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 7,460,732 | $240,012,000 | 28.78% |
Casdin Capital, LLC | 1,500,000 | $48,255,000 | 2.16% |
Flagship Pioneering Inc. | 2,619,968 | $84,284,000 | 1.98% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 38,000 | $8,192,000 | 1.85% |
Yiheng Capital Management, L.P. | 1,014,684 | $32,642,000 | 1.49% |
SECTORAL ASSET MANAGEMENT INC | 207,100 | $6,662,000 | 1.18% |
Artal Group S.A. | 600,000 | $19,302,000 | 0.81% |
GILDER GAGNON HOWE & CO LLC | 2,619,217 | $84,260,000 | 0.78% |
Temasek Holdings (Private) Ltd | 5,369,487 | $172,736,397 | 0.73% |
BRANDYWINE MANAGERS, LLC | 9,601 | $309,000 | 0.53% |